Astellas Pharma AG
- G02 - Otros preparados ginecológicos
- VEOZA film-coated tablet 45 mg
- G04 - Urológicos
- BETMIGA prolonged-release tablet 25 mg
- BETMIGA prolonged-release tablet 50 mg
- OMIX OCAS prolonged-release tablet 0.4 mg
- VESICARE film-coated tablet 10 mg
- VESICARE film-coated tablet 5 mg
- L01 - Antineoplásicos
- PADCEV powder for solution for infusion 20 mg
- PADCEV powder for solution for infusion 30 mg
- VYLOY powder for solution for infusion 100 mg
- XOSPATA film-coated tablet 40 mg
- L02 - Terapia endocrina
- XTANDI film-coated tablet 40 mg
- XTANDI film-coated tablet 80 mg
- L04 - Inmunosupresores
- ADVAGRAF prolonged-release capsule, hard 0.5 mg
- ADVAGRAF prolonged-release capsule, hard 1 mg
- ADVAGRAF prolonged-release capsule, hard 3 mg
- ADVAGRAF prolonged-release capsule, hard 5 mg
- MODIGRAF granules for oral suspension 0.2 mg
- MODIGRAF granules for oral suspension 1 mg
- PROGRAF capsule, hard 0.5 mg
- PROGRAF capsule, hard 1 mg
- PROGRAF capsule, hard 5 mg
- PROGRAF concentrate for solution for infusion 5 mg/ml